Study outcomes
ADVERSE EVENTS
The primary outcome was KFR on day 7 (sCr return to <0.30 mg/dL from the baseline value). Secondary outcomes included variables related to KFR during the treatment and the follow-up period, namely, the change in urinary volume, percentage of decrease in sCr levels, in-hospital mortality, mortality during follow-up, KRT requirement, electrolyte levels and acid–base abnormalities. The prespecified adverse events mentioned above were prospectively reported.